Precision medicine firm shares in £16m funding to advance technology

A trailblazing Manchester company is among 13 UK SMEs sharing £16m of Government funds aimed at preventing and treating diseases, including cancer and heart disease. Microbiosensor is developing a novel low-cost diagnostic same-day test for urinary tract infections. Their technology will alert patients and/or physicians to an escalating infection to ensure the appropriate antibiotics prescription. It is one of 13 ‘precision medicine’ projects from UK-based SMEs that will use a combination of information about a patient... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close